First, there was opium

The first in a series on opioid addiction

 

How do opioids relieve pain, cause euphoria and lead to an addiction that refuses to take “no” for an answer? How is it that in 2017, 72,000 Americans died of opioid drug overdose? What is the chemistry behind this catastrophe? Is there any hope of controlling it?

Scratch the seed bulb of a poppy plant with a knife and a milky white latex secretion oozes out. This raw opium contains morphine, codeine and thebaine. The first two are pain-relievers of the first order; thebaine is the molecule from which chemists (or criminals) make oxycodone, fentanyl and other semi-synthetic opiates. Laudenum is an alcohol extract (or tincture) of opium and was widely used as a sedative and painkiller in Europe and the United States in the 19th and early 20th centuries, until physicians and users realized how addictive it was.  Codeine, the second component of opium, is an effective pain reliever and cough suppressant and is still widely used. 

Morphine was purified from opium and sold by Merck in 1827.  Heroin, a chemical variation, is more potent than morphine, partly because it can cross the blood-brain barrier and has greater access to the central nervous system. Created by Bayer in 1874, it was sold for pain relief. Heroin was also used to control diarrhea because it affects the gut, which has its own dedicated branch of the nervous system. 

Cocaine, from the coca plant, is in a separate chemical family. Heroin mixed with cocaine is particularly potent at blocking the nerve impulses that control breathing. Many of the drug-associated deaths in the United States are the result of this or other drug mixtures, according to the National Institute of Drug Abuse (NIDA).

Opioids can be smoked, snorted or swallowed as pills or tinctures, but the invention of the syringe (about 1857) provided another way to get drugs into the bloodstream in a sudden way and to induce rapid pain relief and euphoria. In our current epidemic, contaminated syringes increase the risk of infection — notably for hepatitis, HIV and bacterial infections of the heart valves. At great expense and effort, modern medicine can deal with these conditions, but only for patients who remain drug free and participate in their treatment. 

uuu

Pain is an overriding medical problem and always has been. Consider this statement from a physician in 1915 on the entire collection of drugs then available: If the entire materia medica at our disposal were limited to the choice and use of only one drug, I am sure that a great many, if not the majority, of us would choose opium…” A hundred years later we have many synthetic opioids (hundreds, at least) from oxycodone to fentanyl. The number of surgical procedures — tens of thousands of hip and knee replacements and other procedures each year — would be impossible without pain suppression that currently depends on opioids.

Since chronic pain is central to the addiction crisis, I was surprised to learn how little we know about the neuronal mechanisms that are responsible for it. According to one recent review I read by Dr. Christophe Stein in The Annual Review of Medicine (2016): “The central integration of signals from excitatory and inhibitory neurotransmitters and from cognitive, emotional, and environmental factors results in the perception of ‘pain.’” I offer this statement as proof of complexity. Unlike the acute pain of a stubbed toe, chronic pain, when established, takes up residence in the nervous system and is hard to treat. 

uuu

Chronic pain is also hard to study. First, pain is subjective: reported severity varies from one person to the next. Second, to study pain relief, one has to cause chronic pain and that we cannot do with human beings. Pain is even hard to study in mice. A mouse can’t rate its discomfort on a scale of 1 to 10. Humans are not so reliable either. Third, the nervous system is unique: if pain is inflicted on it or morphine is given to relieve that pain, the nervous system learns. It builds new connections (synapses) between neurons, removes others, and activates new genes. It is no longer the same brain as before addiction. Even when the source of pain is removed, parts of the brain may still signal that pain exists and that it needs that heroin, desperately. We’ll examine the basis of this need in the next column.

For later columns, I will be joined by former Executive Director of Emergency Medical Services in New York City James T. Kerr, who after that post was a senior civil servant in the U.S. Department of Health and Human Services. He will help us understand the spread and cost of the opioid epidemic. 

 

Richard Kessin, PhD, is Professor Emeritus of Pathology and Cell Biology at Columbia University. He lives in Norfolk, Conn., and can be reached at Richard.Kessin@gmail.com. Contact him for original references.

 

Latest News

‘Vulnerable Earth’ opens at the Tremaine Gallery

Tremaine Gallery exhibit ‘Vulnerable Earth’ explores climate change in the High Arctic.

Photo by Greg Lock

“Vulnerable Earth,” on view through June 14 at the Tremaine Gallery at Hotchkiss, brings together artists who have traveled to one of the most remote regions on Earth and returned with work shaped by first-hand experience of a fragile, rapidly shifting planet, inviting viewers to sit with the tension between awe and loss, beauty and vulnerability.

Curated by Greg Lock, director of the Photography, Film and Related Media program at The Hotchkiss School, the exhibition centers on participants in The Arctic Circle, an expeditionary residency that sends artists and scientists into the High Arctic aboard a research vessel twice a year. The result is a show documenting their lived experience and what it means to stand in a place where climate change is not theoretical but visible, immediate and accelerating.

Keep ReadingShow less
Beyond Hammertown: Joan Osofsky designs what comes next

Joan Osofsky and Sharon Marston

Provided

Joan Osofsky is closing the doors on Hammertown, one of the region’s most beloved home furnishings and lifestyle destinations, after 40 years, but she is not calling it an ending.

“I put my baby to bed,” she said, describing the decision with clarity and calm. “It felt like the right time.”

Keep ReadingShow less
A celebratory season of American classics and new works at Barrington Stage Company
Playwright Keelay Gipson’s “Estate Sale” will have its world premier this summer at Barrington Stage Company.
Provided

Amid the many cultural attractions in the region, the Barrington Stage Company in Pittsfield, Massachusetts, stands out for its award-winning productions and comprehensive educational and community-based programming. The theater’s 2026 season is one of its most ambitious; it includes two Pulitzer Prize-winning modern classics, one of the greatest theatrical farces ever written, and new works that speak directly to who we are right now as a society.

“Our 2026 season is a celebration of extraordinary storytelling in all its forms — timeless, uproarious and boldly new,” said Artistic Director Alan Paul. “This season features works that have shaped the American theater, as well as world premieres that reflect the company’s deep commitment to developing new voices and new stories. Together, these productions embody what BSC does best: entertain, challenge and connect our audiences through theater that feels both essential and alive.”

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Hotchkiss Film Festival celebrates 15th year of emerging filmmakers

Student festival directors Trey Ramirez (at the mic) and Leon Li introducing the Hotchkiss Film Festival.

Brian Gersten

The 15th annual Hotchkiss Film Festival took place Saturday, April 25, marking a milestone year for a student-driven event that continues to grow in ambition, reach and artistic scope. The festival was founded in 2012 by Hotchkiss alumnus and Emmy-nominated filmmaker Brian Ryu. Ryu served as a festival juror for this year’s installment, which showcased a selection of emerging filmmakers from around the region. The audience was treated to 17 films spanning drama, horror, comedy, documentary and experimental forms — each reflecting a distinct voice and perspective.

This year’s program was curated by student festival directors Trey Ramirez and Leon Li, working alongside faculty adviser Ann Villano. With more than 52 submissions received, the selection process was both rigorous and rewarding. The final lineup included six films from Hotchkiss students.

Keep ReadingShow less
Artist Maira Kalman curates ‘Shaker Outpost’ in Chatham

The Laundry Room, a painting by Maira Kalman from the exhibition “Shaker Outpost: Design, Commerce, and Culture” at the Shaker Museum’s pop-up space in Chatham.

Photo by Maira Kalman; Courtesy of the artist and Mary Ryan Gallery, New York

With “Shaker Outpost: Design, Commerce, and Culture,” opening May 2, the Shaker Museum in Chatham invites artist and writer Maira Kalman to pair her own new paintings with objects from the museum’s vast holdings, and, in the process, reintroduce the Shakers not as relic, but as a living argument for clarity, usefulness and grace.

Born in Tel Aviv, Maira Kalman is a New York–based artist and writer known for her illustrated books, wide-ranging collaborations and distinctive work spanning publishing, design and fine art.

Keep ReadingShow less

Ticking Tent spring market returns

Ticking Tent spring market returns

The Ticking Tent Spring Market returns to Spring Hill Vineyards in New Preston on May 2.

Jennifer Almquist

The Ticking Tent Spring Market returns to New Preston Saturday, May 2, bringing more than 60 antiques dealers, artisans and design brands to Spring Hill Vineyards for a one-day, brocante-style shopping event from 9 a.m. to 4 p.m.

Co-founders Christina Juarez and Benjamin Reynaert invite visitors to the outdoor market at 292 Bee Brook Road, where curated vendors will offer home goods, fashion, tabletop and collectible design. Guests can browse while enjoying Spring Hill Vineyards’ wines and seasonal fare.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.